Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Hunt

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
International Journal of Biological Macromolecules|July 13, 2025
A cold-adapted endo-fucoidanase Psf1 from Pseudoalteromonas sp. that catalyzes production of T-cell activating fucoidan oligosaccharides from Saccharina latissima fucoidanVo Thi Dieu Trang, Maria Dalgaard Mikkelsen, Monica Daugbjerg Christensen, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cellsSophia N Karagiannis, Marguerite G Bracher, Rebecca L Beavil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cellsSophia N Karagiannis, Marguerite G Bracher, James Hunt, et al.
Nature Communications|April 30, 2026
Far-reaching volcaniclastic density current deposits as evidence of explosive marine eruptionsJacob A Nash, Isobel A Yeo, Michael A Clare, et al.
Nature Communications|November 5, 2023
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradationAlice Fletcher, Dean Clift, Emma de Vries, et al.
Communications Biology|September 19, 2024
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymesJonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, et al.
Cancer Immunology, Immunotherapy : CII|October 23, 2008
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cellsPanagiotis Karagiannis, Josef Singer, James Hunt, et al.
Nature Communications|May 31, 2022
Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failureErwin De Genst, Kylie S Foo, Yao Xiao, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
International Journal of Biological Macromolecules|July 13, 2025
A cold-adapted endo-fucoidanase Psf1 from Pseudoalteromonas sp. that catalyzes production of T-cell activating fucoidan oligosaccharides from Saccharina latissima fucoidanVo Thi Dieu Trang, Maria Dalgaard Mikkelsen, Monica Daugbjerg Christensen, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2007
Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cellsSophia N Karagiannis, Marguerite G Bracher, Rebecca L Beavil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cellsSophia N Karagiannis, Marguerite G Bracher, James Hunt, et al.
Nature Communications|April 30, 2026
Far-reaching volcaniclastic density current deposits as evidence of explosive marine eruptionsJacob A Nash, Isobel A Yeo, Michael A Clare, et al.
Nature Communications|November 5, 2023
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradationAlice Fletcher, Dean Clift, Emma de Vries, et al.
Communications Biology|September 19, 2024
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymesJonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, et al.
Cancer Immunology, Immunotherapy : CII|October 23, 2008
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cellsPanagiotis Karagiannis, Josef Singer, James Hunt, et al.
Nature Communications|May 31, 2022
Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failureErwin De Genst, Kylie S Foo, Yao Xiao, et al.
Pageof 5